School of Materials Science and Engineering, and Tianjin Key Laboratory of Composite and Functional Materials, Tianjin University, Tianjin, 300350, China.
J Biomed Mater Res A. 2019 Feb;107(2):371-382. doi: 10.1002/jbm.a.36548. Epub 2018 Nov 21.
Clinical utility of small-diameter vascular grafts is still challenging in blood vessel regeneration owing to thrombosis and intimal hyperplasia. To cope with the issues, modulation of gene expression via microRNAs (miRNAs) could be a feasible approach by rational regulating physiological activities of both vascular endothelial cells (VECs) and vascular smooth muscle cells (VSMCs). Our previous studies demonstrated that individually loaded miRNA-126 (miR-126) or miRNA-145 (miR-145) in the electrospun membranes showed the tendency to promote vascular regeneration. In this work, the bilayered electrospun graft in 1.5-mm diameter was developed by emulsion electrospinning to dual-load miR-126 and miR-145 for target regulation of both VECs and VSMCs, respectively. Accelerated release of miR-126 was achieved by introducing poly(ethylene glycol) in the inner electrospun poly(ethylene glycol)-b-poly(l-lactide-co-caprolactone) ultrafine fibrous membrane, reaching 61.3 ± 1.2% of the cumulative release in the initial 10 days, whereas the outer electrospun poly(l-lactide-co-glycolide) membrane composed of microfibers fulfilled prolonged release of miR-145 for about 56 days. In vivo tests suggested that dual-loading with miR-126 and miR-145 in the bilayered electrospun membranes could modulate both VECs and VSMCs for rapid endothelialization and hyperplasia inhibition as well. It is reasonably expected that dual target-delivery of miR-126 and miR-145 in the electrospun vascular grafts has effective potential for small-diameter vascular regeneration. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 371-382, 2019.
小直径血管移植物在血管再生中由于血栓形成和内膜增生仍然具有挑战性。为了解决这些问题,通过 microRNAs (miRNAs) 对基因表达的调节可能是一种可行的方法,可以合理调节血管内皮细胞 (VECs) 和血管平滑肌细胞 (VSMCs) 的生理活性。我们之前的研究表明,单独加载到电纺膜中的 miRNA-126 (miR-126) 或 miRNA-145 (miR-145) 表现出促进血管再生的趋势。在这项工作中,通过乳液静电纺丝开发了 1.5mm 直径的双层电纺移植物,以分别双重负载 miR-126 和 miR-145,分别针对 VECs 和 VSMCs 进行靶向调节。通过在内部电纺聚乙二醇-b-聚(L-丙交酯-co-己内酯)超细微纤维膜中引入聚乙二醇 (PEG) ,实现了 miR-126 的加速释放,在最初的 10 天内达到了 61.3±1.2%的累积释放量,而由微纤维组成的外部电纺聚(L-丙交酯-co-乙交酯)膜则实现了 miR-145 的延长释放,约 56 天。体内试验表明,双层电纺膜中双重加载 miR-126 和 miR-145 可以调节 VECs 和 VSMCs,从而实现快速内皮化和抑制过度增生。合理地预期,电纺血管移植物中 miR-126 和 miR-145 的双重靶向输送具有促进小直径血管再生的有效潜力。© 2018 Wiley Periodicals, Inc. J 生物材料 res 部分 A:107A:371-382, 2019.